Recombinant Human Erythropoietin: 18 Months' Experience in Hemodialysis Patients
- 1 February 1990
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 15 (2), 169-175
- https://doi.org/10.1016/s0272-6386(12)80515-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Erythropoietin-Associated Hypertension: What Role for Blood Viscosity Changes?Nephron, 1989
- Working capacity is increased following recombinant human erythropoietin treatmentKidney International, 1988
- Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophyJournal Of Hypertension, 1988
- Recombinant Human Erythropoietin: Implications for NephrologyAmerican Journal of Kidney Diseases, 1988
- Human Recombinant Erythropoietin in Anaemic Patients on Maintenance Haemodialysis. Secondary effects of the Increase of HaemoglobinNephrology Dialysis Transplantation, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986